A detailed history of Isthmus Partners, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 11,145 shares of TWST stock, worth $470,653. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,145
Previous 11,145 -0.0%
Holding current value
$470,653
Previous $549,000 8.38%
% of portfolio
0.06%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$27.95 - $53.0 $61,909 - $117,395
-2,215 Reduced 16.58%
11,145 $549,000
Q1 2023

May 10, 2023

BUY
$14.6 - $30.9 $195,056 - $412,824
13,360 New
13,360 $201,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.38B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.